PortfoliosLab logo

Agile Therapeutics, Inc. (AGRX)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Agile Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $9 for a total return of roughly -99.91%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%NovemberDecember2023FebruaryMarch
-35.71%
6.47%
AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AGRX

Agile Therapeutics, Inc.

Return

Agile Therapeutics, Inc. had a return of -7.49% year-to-date (YTD) and -97.87% in the last 12 months. Over the past 10 years, Agile Therapeutics, Inc. had an annualized return of -54.64%, while the S&P 500 had an annualized return of 8.56%, indicating that Agile Therapeutics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-22.22%-5.31%
Year-To-Date-7.49%2.01%
6 months-47.50%0.39%
1 year-97.87%-10.12%
5 years (annualized)-71.99%7.32%
10 years (annualized)-54.64%8.56%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202318.94%-11.11%
2022-26.30%-6.06%-24.73%8.10%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Agile Therapeutics, Inc. Sharpe ratio is -0.64. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20NovemberDecember2023FebruaryMarch
-0.64
-0.43
AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Agile Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-99.96%
-18.34%
AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Agile Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Agile Therapeutics, Inc. is 99.97%, recorded on Dec 20, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.97%Apr 17, 20151935Dec 20, 2022
-45.35%Jun 25, 2014122Dec 16, 201449Feb 27, 2015171
-20.5%Mar 5, 201515Mar 25, 20158Apr 7, 201523
-9.22%Jun 4, 20142Jun 5, 20144Jun 11, 20146
-3.04%Jun 20, 20141Jun 20, 20141Jun 23, 20142
-2.02%Jun 16, 20141Jun 16, 20141Jun 17, 20142
-1.52%May 30, 20141May 30, 20141Jun 2, 20142
-0.51%Apr 9, 20151Apr 9, 20151Apr 10, 20152
-0.37%Mar 2, 20151Mar 2, 20151Mar 3, 20152

Volatility Chart

Current Agile Therapeutics, Inc. volatility is 43.00%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%NovemberDecember2023FebruaryMarch
43.00%
21.17%
AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)